United States· US:23155-148_dc1b5c0e-cd6b-482e-9388-e9183ca499e9

Acarbose

A acarbose product containing acarbose, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 13 of our 19 countries.

ATC A10BF01

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about acarboseAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Acarbose is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BF01 (acarbose), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search acarbose products by name

Acarbose · ATC A10BF01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Finlandprice
Franceprice
Germany
Italyprice
Japan
Norwayprice
Polandprice
Spainprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acarbose costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.52 in Spain to $1.01 in United States — a ×1.9 gap.

United States: $1.01 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Acarbose · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

US United States$1.01 (acquisition cost)
IT Italy$0.96
FR France$0.65
ES Spain$0.52

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: ACARBOSE
Manufacturer: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country: United States (US)
ATC code: A10BF01
ATC class: Acarbose
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 3

ndc11
23155-148-01
ndc11
23155-148-05
ndc11
23155-148-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for acarbose.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check acarbose against other medicines How interaction checks work

Acarbose · interactions on record

461 records

8 severe
262 moderate
46 minor
145 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
GatifloxacinJ01MA16severe
PexidartinibL01EX15severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acarbose in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acarbose products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

Bulgaria · Ароба
Czechia · Acarbose Viatris
Germany · Acarbose Al, Acarbose Dura
Spain · Acarbosa Farmalider, Acarbosa Qualigen
France · Acarbose Arrow, Acarbose Arrow Lab
United Kingdom (Northern Ireland) · Acarbose, Acarbose Generics [uk] Ltd
Italy · Acarbosio Aurobindo, Acarbosio Doc Generici
Poland · Acarbose Aurovitas, Adeksa
Portugal · Acarbose Berar Laboratórios Basi - Indústria Farmacêutica, Acarbose Bluepharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/06606c50-b2ee-4aea-a699-605e07206a9c
GET /v1/drugs/06606c50-b2ee-4aea-a699-605e07206a9c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "ACARBOSE",
  "productndc": "23155-148",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202271",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about acarbose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console